Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 23Terminated 6Withdrawn 3Unknown 3Recruiting 3Active not recruiting 1

Sponsor Class

UNKNOWN 1OTHER_GOV 1OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3

Conditions

Breast Neoplasms 69Carcinoma, Non-Small-Cell Lung 60Stomach Neoplasms 32Prostatic Neoplasms 21Nasopharyngeal Carcinoma 20Lung Neoplasms 20Squamous Cell Carcinoma of Head and Neck 11Esophageal Neoplasms 10Neoplasm Metastasis 8Head and Neck Neoplasms 7Inflammatory Breast Neoplasms 6Pancreatic Neoplasms 5Neoplasms 5HER2-positive Breast Cancer 5Triple Negative Breast Neoplasms 4Ovarian Neoplasms 4NSCLC 4Carcinoma, Squamous Cell 4Adenocarcinoma 4Sarcoma 3Nasopharyngeal Neoplasms 3Hypopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Ovarian Epithelial 3Breast Diseases 3Adenocarcinoma of Lung 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tongue Neoplasms 2Squamous Cell Lung Cancer 2

Interventions

Doxorubicin 19Radiotherapy 10Ifosfamide 10apatinib 9anlotinib 8Cyclophosphamide 8camrelizumab 7Vincristine 5Dactinomycin 5toripalimab 3Trabectedin 3Radiation Dose Hypofractionation 3Etoposide 3Docetaxel 3ribociclib 2brostallicin 2Topotecan 2Thalidomide 2Temozolomide 2Sorafenib 2Oncolytic Virotherapy 2Nivolumab 2Neoadjuvant Therapy 2Melphalan 2Magnetic Resonance Spectroscopy 2Irinotecan 2Ipilimumab 2Immune Checkpoint Inhibitors 2Gene Expression Profiling 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Sarcoma × Docetaxel × Clear all
NCT01380275 2014-09-25

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

National Cancer Center, Korea

Phase 2 Unknown
35 enrolled
Sarcoma

Recurrence, Sarcoma

NCT01812018 2013-03-15

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

ChineseAMS

Phase 2 Unknown
30 enrolled
Sarcoma

Sarcoma

NCT00807261 2008-12-12

Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy

Asan Medical Center

Phase 2 Unknown
30 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡